Eastman Kodak Launches Saline Line in Rochester
The company has introduced a new pharmaceutical-grade saline solution and a dedicated online store for U.S. customers.
Updated on Oct. 28, 2026 in Healthcare
Live Poll
Do you trust established non-healthcare brands to produce essential medical and pharmaceutical products?
Eastman Kodak Company announced the launch of KODAK Normal Saline, a 0.9% pharmaceutical-grade buffer and reagent. The product is manufactured at the company's facility in Rochester.
Why it matters
This product expansion targets laboratory and bioprocessing clients by providing essential chemical reagents through a new direct-to-consumer digital storefront.
The new KODAK Normal Saline is formulated as a 0.9% concentration buffer. This product is manufactured specifically for laboratory and bioprocessing applications.
The players
Eastman Kodak Company
An American technology company that produces imaging and chemical products for both consumer and industrial markets.
The details
The newly launched online storefront allows pharmaceutical, biotechnology, and life science customers across the United States to purchase the buffer directly. The solution serves as a critical reagent for high-precision scientific research and industrial processes.
Timeline
Wednesday, October 28, 2026: Eastman Kodak Company announced the new product and store.
Market Landscape
This move capitalizes on the growing demand for specialized laboratory supplies within the domestic life sciences industry. By centralizing distribution through an online portal, Eastman Kodak Company positions itself to compete more directly for B2B procurement contracts.
Biotechnology and pharmaceutical researchers in the U.S. now have a direct channel to source this reagent for their laboratory workflows. This shift in procurement aims to streamline supply chains for professional entities requiring standardized chemical buffers.
The takeaway
The move demonstrates how traditional industrial manufacturers can leverage specialized production facilities to enter the high-stakes laboratory supply market. Customers should verify that their specific laboratory protocols align with the 0.9% pharmaceutical-grade formulation provided by the new line.
Further reading
For more on industry developments, visit Healthcare.
Live Poll
Do you trust established non-healthcare brands to produce essential medical and pharmaceutical products?
